Corbus Pharmaceuticals Holdings, Inc. (CRBP)
7.80
-0.11
(-1.39%)
USD |
NASDAQ |
May 27, 16:00
7.90
+0.10
(+1.28%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 126.34M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -221.22M |
| Curis, Inc. | 12.71M |
| Plus Therapeutics, Inc. | 11.96M |
| Windtree Therapeutics, Inc. | -11.60M |
| Halozyme Therapeutics, Inc. | 219.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 144.48M |
| Total Liabilities (Quarterly) | 18.14M |
| Debt to Equity Ratio | 0.0095 |
| Current Ratio | 7.915 |
| Net Debt Paydown Yield | 0.24% |